Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Temozolomide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1487941A details a safer, scalable route for temozolomide production, offering significant cost reduction in API manufacturing and enhanced supply chain stability for global buyers.
Novel patent CN113493458B offers safer temozolomide production without methyl isocyanate ensuring high purity and supply chain stability for pharmaceutical intermediates.
Patent CN1269819C reveals a safer synthetic route for temozolomide, eliminating hazardous reagents and improving yield for cost reduction in API manufacturing.
Patent CN1300143C reveals a DMSO-based purification method achieving 99.9% purity. Offers cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel patent CN113493417B details high-purity Temozolomide intermediate VII synthesis. Offers safer, scalable pharmaceutical intermediate manufacturing solutions.
Patent CN102285991A details an acid-assisted acetone/water refining method for Temozolomide, achieving over 99.5% purity with significant cost and supply chain advantages.
Novel patent CN114805360B details safer temozolomide preparation avoiding toxic reagents, ensuring high purity and supply chain stability for pharmaceutical manufacturing.